Viewing Study NCT04809467

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-02-23 @ 3:01 PM
Study NCT ID: NCT04809467
Status: COMPLETED
Last Update Posted: 2025-08-03
First Post: 2021-03-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study Evaluating Safety, PK, and Efficacy of Tafasitamab and Parsaclisib in Participants With Relapsed/Refractory Non Hodgkin Lymphoma (R/R NHL) or Chronic Lymphocytic Leukemia (CLL)
Sponsor: Incyte Corporation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Lymphocytic Leukemia View
None Non Hodgkin Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None parsaclisib View
None MOR00208 View
None INCMOR00208 View
None Relapsed or Refractory View
None Leukemia View
None tafasitamab View